Literature DB >> 16769111

Angiogenic and inflammatory response to biodegradable scaffolds in dorsal skinfold chambers of mice.

Martin Rücker1, Matthias W Laschke, Dominik Junker, Carlos Carvalho, Alexander Schramm, Rolf Mülhaupt, Nils-Claudius Gellrich, Michael D Menger.   

Abstract

For tissue engineering, scaffolds should be biocompatible and promote neovascularization. Because little is known on those specific properties, we herein studied in vivo the host angiogenic and inflammatory response after implantation of commonly used scaffold materials. Porous poly(L-lactide-co-glycolide) (PLGA) and collagen-chitosan-hydroxyapatite hydrogel scaffolds were implanted into dorsal skinfold chambers of balb/c mice. Additional animals received cortical bone as an isogeneic, biological implant, while chambers of animals without implants served as controls. Angiogenesis and neovascularization as well as leukocyte-endothelial cell interaction and microvascular permeability were analyzed over 14 day using intravital fluorescence microscopy. PLGA scaffolds showed a slight increase in leukocyte recruitment compared to controls. This was associated with an elevation of microvascular permeability, which was comparable to that observed in isogeneic bone tissue. Of interest, PLGA induced a marked angiogenic response, revealing a density of newly formed capillaries almost similar to that observed in bone implants. Histology showed infiltration of macrophages, probably indicating resorption of the biomaterial. In contrast, hydrogel scaffolds induced a severe inflammation, as indicated by an approximately 15-fold increase of leukocyte-endothelial cell interaction and a marked elevation of microvascular permeability. This was associated by induction of apoptotic cell death within the surrounding tissue and a complete lack of ingrowth of newly formed microvessels. Histology confirmed adequate engraftment of PLGA and isogeneic bone but not hydrogel within the host tissue. PLGA scaffolds show a better biocompatibility than hydrogel scaffolds and promote vascular ingrowth, guaranteeing adequate engraftment within the host tissue.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16769111     DOI: 10.1016/j.biomaterials.2006.05.033

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  35 in total

1.  Short-term and long-term effects of orthopedic biodegradable implants.

Authors:  Ami R Amini; James S Wallace; Syam P Nukavarapu
Journal:  J Long Term Eff Med Implants       Date:  2011

2.  Basic research on aw-AC/PLGA composite scaffolds for bone tissue engineering.

Authors:  Shiho Minamiguchi; Masaaki Takechi; Tetsuya Yuasa; Yukihiro Momota; Seiko Tatehara; Hideyuki Takano; Youji Miyamoto; Kazuhito Satomura; Masaru Nagayama
Journal:  J Mater Sci Mater Med       Date:  2007-08-15       Impact factor: 3.896

3.  Expansion of microvascular networks in vivo by phthalimide neovascular factor 1 (PNF1).

Authors:  Kristen A Wieghaus; Meghan M Nickerson; Caren E Petrie Aronin; Lauren S Sefcik; Richard J Price; Mikell A Paige; Milton L Brown; Edward A Botchwey
Journal:  Biomaterials       Date:  2008-09-18       Impact factor: 12.479

Review 4.  Manipulating the intersection of angiogenesis and inflammation.

Authors:  Brian J Kwee; David J Mooney
Journal:  Ann Biomed Eng       Date:  2014-10-15       Impact factor: 3.934

5.  Polymers for 3D Printing and Customized Additive Manufacturing.

Authors:  Samuel Clark Ligon; Robert Liska; Jürgen Stampfl; Matthias Gurr; Rolf Mülhaupt
Journal:  Chem Rev       Date:  2017-07-30       Impact factor: 60.622

6.  Quantitative evaluation of the in vivo biocompatibility and performance of freeze-cast tissue scaffolds.

Authors:  Prajan Divakar; Karen L Moodie; Eugene Demidenko; P Jack Hoopes; Ulrike G K Wegst
Journal:  Biomed Mater       Date:  2020-07-23       Impact factor: 3.715

7.  Engineered cell-free scaffold with two-stage delivery of miRNA-26a for bone repair.

Authors:  Joseph Paquet; Adrien Moya; Morad Bensidhoum; Hervé Petite
Journal:  Ann Transl Med       Date:  2016-05

8.  Heme oxygenase (HO)-1 protects from lipopolysaccharide (LPS)-mediated liver injury by inhibition of hepatic leukocyte accumulation and improvement of microvascular perfusion.

Authors:  Jonas Roller; Matthias W Laschke; Claudia Scheuer; Michael D Menger
Journal:  Langenbecks Arch Surg       Date:  2010-03-17       Impact factor: 3.445

Review 9.  Extracellular matrix-based biomaterial scaffolds and the host response.

Authors:  Joseph M Aamodt; David W Grainger
Journal:  Biomaterials       Date:  2016-02-03       Impact factor: 12.479

10.  Influence of poly(D,L-lactic-co-glycolic acid) microsphere degradation on arteriolar remodeling in the mouse dorsal skinfold window chamber.

Authors:  Meghan M Nickerson; Ji Song; Casey W Shuptrine; Kristen A Wieghaus; Edward A Botchwey; Richard J Price
Journal:  J Biomed Mater Res A       Date:  2009-11       Impact factor: 4.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.